Oliger Christy J. insider trades
Oliger Christy J. has filed 26 Form 4s with the SEC that we hold, for Replimune Group, Inc. (REPL) (Director), Karyopharm Therapeutics Inc. (KPTI) (Director), Nuvalent, Inc. (NUVL) (Director) and RETA (Director), among 10 companies in all. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2021-12-03 and the latest 2026-09-02.
Replimune Group, Inc. (REPL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Karyopharm Therapeutics Inc. (KPTI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Nuvalent, Inc. (NUVL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RETA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Vera Therapeutics, Inc. (VERA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
LVTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Bicara Therapeutics Inc. (BCAX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RYZB
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
SRRA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Zenas BioPharma, Inc. (ZBIO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1822092) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms